Ágota Kovács

New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD Cohort

Mária Papp, I Altorjay, Nir Dotan et al. · The American Journal of Gastroenterology · 2008 · 146 citations

IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease

A. Nemetz, M. P. Nosti-Escanilla, Tamás Molnár et al. · Immunogenetics · 1999 · 142 citations

Inflammation, Chronic Inflammatory Diseases, Autoimmune Disease +11

The optimal dose of 5-aminosalicylic acid in active ulcerative colitis: A dose-finding study with newly developed mesalamine

Wolfgang Kruis, Simon Bar–Meir, János Fehér et al. · Clinical Gastroenterology and Hepatology · 2003 · 113 citations

Optimal Dose, Gastrointestinal Pharmacology, Medicine +6

Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis

Simon Bar–Meir, Alexandra Lavy, O Mickisch et al. · Alimentary Pharmacology & Therapeutics · 2005 · 95 citations · Full text

Antioxidant Defense in Erythrocytes and Plasma of Patients with Active and Quiescent Crohn Disease and Ulcerative Colitis: A Chemiluminescent Study

Anna Blázovics, Ágota Kovács, Andrea Lugasi et al. · Clinical Chemistry · 1999 · 81 citations · Full text

Gastrointestinal Pharmacology, Lipid Peroxidation, Immunology +17